S.Biomedics Co., Ltd. (KOSDAQ:304360)
22,100
+500 (2.31%)
Last updated: Sep 17, 2025, 12:39 PM KST
S.Biomedics Revenue
S.Biomedics had revenue of 4.81B KRW in the quarter ending June 30, 2025, with 45.69% growth. This brings the company's revenue in the last twelve months to 17.10B, up 43.65% year-over-year. In the year 2024, S.Biomedics had annual revenue of 13.73B with 4.77% growth.
Revenue (ttm)
17.10B
Revenue Growth
+43.65%
P/S Ratio
17.27
Revenue / Employee
316.60M
Employees
54
Market Cap
295.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.73B | 625.65M | 4.77% |
Dec 31, 2023 | 13.11B | 995.73M | 8.22% |
Dec 31, 2022 | 12.11B | 3.24B | 36.58% |
Dec 31, 2021 | 8.87B | 3.55B | 66.72% |
Dec 31, 2020 | 5.32B | 305.34M | 6.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |